For instance, NPs functionalized with amyloid-beta antibodies or tau-binding peptides have demonstrated efficacy in AD models, enabling imaging of pathological aggregates alongside the delivery of anti-amyloid therapies [52]. The gene discussed is MAPT; the disease is Alzheimer disease.